331 related articles for article (PubMed ID: 35401819)
1. Multifunctional co-transport carriers based on cyclodextrin assembly for cancer synergistic therapy.
Yi S; Liao R; Zhao W; Huang Y; He Y
Theranostics; 2022; 12(6):2560-2579. PubMed ID: 35401819
[TBL] [Abstract][Full Text] [Related]
2. A Comprehensive Review on Cyclodextrin-Based Carriers for Delivery of Chemotherapeutic Cytotoxic Anticancer Drugs.
Gidwani B; Vyas A
Biomed Res Int; 2015; 2015():198268. PubMed ID: 26582104
[TBL] [Abstract][Full Text] [Related]
3. Supramolecular self-assembly forming a multifunctional synergistic system for targeted co-delivery of gene and drug.
Zhao F; Yin H; Li J
Biomaterials; 2014 Jan; 35(3):1050-62. PubMed ID: 24189097
[TBL] [Abstract][Full Text] [Related]
4. Cyclodextrin-based delivery systems for chemotherapeutic anticancer drugs: A review.
Tian B; Hua S; Liu J
Carbohydr Polym; 2020 Mar; 232():115805. PubMed ID: 31952603
[TBL] [Abstract][Full Text] [Related]
5. Cyclodextrin as a magic switch in covalent and non-covalent anticancer drug release systems.
Tian B; Liu Y; Liu J
Carbohydr Polym; 2020 Aug; 242():116401. PubMed ID: 32564836
[TBL] [Abstract][Full Text] [Related]
6. Drug and gene co-delivery systems for cancer treatment.
Yang Z; Gao D; Cao Z; Zhang C; Cheng D; Liu J; Shuai X
Biomater Sci; 2015 Jul; 3(7):1035-49. PubMed ID: 26221938
[TBL] [Abstract][Full Text] [Related]
7. Advantages of the combined use of cyclodextrins and nanocarriers in drug delivery: A review.
Mura P
Int J Pharm; 2020 Apr; 579():119181. PubMed ID: 32112928
[TBL] [Abstract][Full Text] [Related]
8. Cyclodextrin-based Polymeric Nanoparticles as Efficient Carriers for Anticancer Drugs.
Duchene D; Cavalli R; Gref R
Curr Pharm Biotechnol; 2016; 17(3):248-55. PubMed ID: 26517333
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate-based amphiphilic prodrug nanoaggregates for co-administration of multiple therapeutics and synergistic cancer therapy.
Hou M; Gao YE; Shi X; Bai S; Ma X; Li B; Xiao B; Xue P; Kang Y; Xu Z
Acta Biomater; 2018 Sep; 77():228-239. PubMed ID: 30006314
[TBL] [Abstract][Full Text] [Related]
10. Self-assembling prodrug nanotherapeutics for synergistic tumor targeted drug delivery.
Wang Z; Chen J; Little N; Lu J
Acta Biomater; 2020 Jul; 111():20-28. PubMed ID: 32454086
[TBL] [Abstract][Full Text] [Related]
11. Cyclodextrin based nanoparticles for smart drug delivery in colorectal cancer.
Marabada D; Li J; Wei S; Huang Q; Wang Z
Chem Biol Drug Des; 2023 Dec; 102(6):1618-1631. PubMed ID: 37705133
[TBL] [Abstract][Full Text] [Related]
12. Multifunctional nanoparticles for targeted delivery of immune activating and cancer therapeutic agents.
Jia F; Liu X; Li L; Mallapragada S; Narasimhan B; Wang Q
J Control Release; 2013 Dec; 172(3):1020-34. PubMed ID: 24140748
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapeutic drug-photothermal agent co-self-assembling nanoparticles for near-infrared fluorescence and photoacoustic dual-modal imaging-guided chemo-photothermal synergistic therapy.
Li Y; Liu G; Ma J; Lin J; Lin H; Su G; Chen D; Ye S; Chen X; Zhu X; Hou Z
J Control Release; 2017 Jul; 258():95-107. PubMed ID: 28501673
[TBL] [Abstract][Full Text] [Related]
14. Drug-Encapsulated Cyclodextrin Nanosponges.
Tannous M; Caldera F; Hoti G; Dianzani U; Cavalli R; Trotta F
Methods Mol Biol; 2021; 2207():247-283. PubMed ID: 33113141
[TBL] [Abstract][Full Text] [Related]
15. A vision for cyclodextrin nanoparticles in drug delivery systems and pharmaceutical applications.
Lakkakula JR; Maçedo Krause RW
Nanomedicine (Lond); 2014 May; 9(6):877-94. PubMed ID: 24981652
[TBL] [Abstract][Full Text] [Related]
16. Carrier-free nanodrug: A novel strategy of cancer diagnosis and synergistic therapy.
Yang MY; Zhao RR; Fang YF; Jiang JL; Yuan XT; Shao JW
Int J Pharm; 2019 Oct; 570():118663. PubMed ID: 31493497
[TBL] [Abstract][Full Text] [Related]
17. Supramolecular micelles as multifunctional theranostic agents for synergistic photodynamic therapy and hypoxia-activated chemotherapy.
Huang X; Chen T; Mu N; Lam HW; Sun C; Yue L; Cheng Q; Gao C; Yuan Z; Wang R
Acta Biomater; 2021 Sep; 131():483-492. PubMed ID: 34265471
[TBL] [Abstract][Full Text] [Related]
18. Biological stimuli-responsive cyclodextrin-based host-guest nanosystems for cancer therapy.
Dan Z; Cao H; He X; Zeng L; Zou L; Shen Q; Zhang Z
Int J Pharm; 2015 Apr; 483(1-2):63-8. PubMed ID: 25639701
[TBL] [Abstract][Full Text] [Related]
19. Opportunities and challenges for co-delivery nanomedicines based on combination of phytochemicals with chemotherapeutic drugs in cancer treatment.
Gao Q; Feng J; Liu W; Wen C; Wu Y; Liao Q; Zou L; Sui X; Xie T; Zhang J; Hu Y
Adv Drug Deliv Rev; 2022 Sep; 188():114445. PubMed ID: 35820601
[TBL] [Abstract][Full Text] [Related]
20. The use of cyclodextrin inclusion complexes to improve anticancer drug profiles: a systematic review.
Gandhi SR; Quintans JSS; Gandhi GR; Araújo AAS; Quintans Júnior LJ
Expert Opin Drug Deliv; 2020 Aug; 17(8):1069-1080. PubMed ID: 32515613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
